Generic Victrelis Availability
Last updated on Sep 11, 2024.
Victrelis is a brand name of , approved by the FDA in the following formulation(s):
VICTRELIS (boceprevir - capsule;oral)
-
Manufacturer: MERCK SHARP DOHME
Approval date: May 13, 2011
Strength(s): 200MG (discontinued)
All of the above formulations have been discontinued.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Victrelis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
Related patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
-
Patent 7,772,178
Patent expiration dates:
- November 11, 2027✓✓
- November 11, 2027
-
Administration of HCV protease inhibitors in combination with food to improve bioavailability
Patent 8,119,602
Issued: February 21, 2012
Inventor(s): Zhang Jenny & Gupta Samir K.
Assignee(s): Schering CorporationMethods of treating, preventing or ameliorating one or more symptoms of hepatitis C in a subject comprising the step of administering at least one HCV protease inhibitor in combination with food are provided. Also provided are methods of increasing bioavailability of an HCV protease inhibitor and methods of increasing serum levels of an HCV protease inhibitor in a subject. All methods comprise adminstering at least one HCV protease inhibitor in combination with food, the at least one HCV protease inhibitor selected from the group consisting of compounds of Formulae I-XXVI, described herein. Administration of compounds of the present invention in combination with food provides improved bioavailability and increased peak serum levels of the compounds as compared to administration without food.
Patent expiration dates:
- March 17, 2027✓
- March 17, 2027
-
Peptides as NS3-serine protease inhibitors of hepatitis C virus
Patent RE43298
Issued: April 3, 2012
Inventor(s): Saksena Anil K. & Girijavallabhan Viyyoor Moopil & Lovey Raymond G. & Jao Edwin & Bennett Frank & McCormick Jinping L. & Wang Haiyan & Pike Russell E. & Bogen Stephane L. & Chan Tin-Yau & Liu Yi-Tsung & Zhu Zhaoning & Njoroge F. George & Arasappan Ashok & Parekh Tejal & Ganguly AshitThe present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Patent expiration dates:
- December 22, 2024✓✓✓
- December 22, 2024
More about Victrelis (boceprevir)
- Victrelis consumer information
- Check interactions
- Compare alternatives
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: protease inhibitors
- Breastfeeding
Related treatment guides
Glossary
Term | Definition |
---|---|
Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.